The literature on malignant cardiac tumors is relatively limited because they are rare, especially among the Chinese population. We analyzed 14 patients diagnosed with malignant cardiac tumors in Fuwai Hospital and present the results of surgical treatments on the tumors. The mean age at tumor diagnosis was 47 years in a male-dominated cohort. There was a high frequency of pericardial effusion and coronary artery involvement in our group. We compared the survival times of patients who received different treatments and found that surgery improved prognosis of tumors, especially for patients who underwent orthotopic heart transplantation.
T umors of the heart and the great vessels are very rare, especially malignant ones, constituting only 3% to 28 .7% of all heart tumors; 1) an even lower prevalence of 34 cases per 100 million persons has been reported recently. 2) Because of the limited number of cases, knowledge of malignant cardiac tumors (MCTs) was usually obtained from studies based on small samples, and most of the reported works were case reports. On the other hand, cardiac manifestations vary with the anatomical locations and histological types of the tumors, 3) so complex clinical phenotypes impose great challenges in unraveling the disease pathogenesis.
The major treatment for primary cardiac tumors is surgery; however, complete resection is hardly achievable due to tumor inaccessibility and the vital roles of cardiac structures, 4) so heart transplantation may be an alternative for unresectable tumors. 5) Evaluation reports regarding the effectiveness of different surgical treatments are still limited.
Although some MCT characteristics have been summarized from a large-scale national registry study, 2, 6) Chinese population data remains rare, especially research based on more than 10 patients. 7) We collected clinical information from 14 patients diagnosed with MCTs in Fuwai Hospital between 2005 and 2016. The purpose of this analysis is to clarify the clinical characteristics, histopathology, and outcomes of primary cardiac tumors.
Methods
Study subjects and procedure: Between 2005 and 2016, the Fuwai Hospital patient database was searched to identify patients whose MCT diagnoses were confirmed by cardiovascular imaging or pathology examination. Their medical records were reviewed with approval from the Fuwai Clinic Institutional Review Board. Patient followup data were obtained by phone. We performed subgroup analyses based on treatments (non-surgery, tumor resection, and heart transplantation). One patient was excluded from the survival analysis for lack of follow-up information. All categorical variables were presented as frequencies and percentages. When appropriate, mean (SD) was presented for continuous data variables. Overall survival was defined as the time elapsed from the date of diagnosis until death. Survival was estimated using the KaplanMeier product limit method, and curves were compared using a log-rank test. To analyze overall survival, events were defined as death from any cause. The data were managed and analyzed by SPSS software version 23. Immunohistochemical staining: Immunohistochemical staining was performed with the following monoclonal (mc) and polyclonal (pc) antibodies: SDHB (pc, 1:1000, GUO, ET AL 
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Results
Clinical characteristics of patients: Overall, the mean age at tumor diagnosis was 47 ± 16.5 years. Unlike previous reports, more male patients were affected (64%, n = 9) in our group. More than half the patients (57.1%, n = 8) presented with pericardial effusion, although most tumors were not located in, or invaded, the pericardium. Thirty-five percent of the patients presented in the New York Heart Association (NYHA) III/IV category. The most common presenting complaint was dyspnea. Eleven patients had electrocardiographic abnormalities with high frequency of T wave changes (Table I) . Diagnosis: All patients were diagnosed with echocardiography, some confirmed by cardiac magnetic resonance imaging (MRI n = 7, 50%) and computed tomography (CT n = 6, 42.9%). Pathology diagnosis were made after cardiac surgery. The types and locations of tumors are shown in Table II . Most of the tumors were sarcomas. The right atrium was more susceptible to tumors, especially for angiosarcomas. Four malignant tumors diagnosed by echocardiography invaded right ventricle. Six tumors involved coronary artery. All patients' whose valves were impacted by tumors showed valve insufficiency. The left ventricle and pericardium were less frequently invaded.
Overall survival: Survival data were available for 13 patients (92.9%). Within a mean follow-up period of 26 months, 11 patients died ( Figure 1 ). We divided our patients into three groups based on treatments. The surgery group (n = 7) had a better survival than nonsurgical patients (n = 4) with a three-month survival rate of 100% versus 0 (P =0.001). While survival analysis revealed that > 70% of the surgical patients died within 12 months after diagnosis, two patients who received heart transplantation in 2005 are still alive today with no complications. Tumors invaded coronary artery: Coronary artery affected by tumors was rarely found in previous study, however, in our study cohort, 42.9% patients showed coronary artery invaded. They often complained of increasing dyspnea and chest pain after physical activity. The right coronary artery was more frequently affected in cardiac tumors. T wave changes were found in all patients during electrocardiography (ECG) examination. A 48-year-old woman with pheochromocytoma complained of paroxysmal palpitation and onset of dizziness after activity. Echocardiography and MRI examination showed a mediumsized mass, measuring 7 cm x 5 cm, in the pericardial cavity at the aortic root, encompassing the left coronary artery and extending to the anterior ( Figure 2A ) and lateral wall of the left ventricle. A preoperative coronary angiogram demonstrated a coronary artery triple vessel lesion due to tumor compression ( Figure 2B ). Pathology characteristics of pheochromocytoma: Cardiac pheochromocytomas without adrenal involvement are rare, so to better understand this disease, immumohistochemical staining was done to determine some pathology characteristics. However, in pheochromocytoma, cardiac toxic hormones secreted by tumors, such as dopamine and norepinephrine, could cause acute myocarditis, 8) so we evaluated inflammatory status in the heart. As shown in Figure 3 , there was more lymphocyte infiltration in the myocardium of the pheochromocytoma patient than the sarcoma patient, while both specimens exhibited macrophage infiltration. The mutation of succinate dehydroge-THE CHARACTERISTICS OF PRIMARY CARDIAC TUMORS Figure 1 . Overall survival (OS) comparison between patients with different treatments. The OS of resected patients was superior to nonoperated patients (log-rank P = 0.001). The P value in the figure is calculated from the log-rank test comparing different treatments among the three groups. nase subunit B (SDHB) has been considered a pathogenic factor. 9) SDHB immunohistochemistry was done on the heart specimen of this patient, finding SDHB expression decreased dramatically compared to normal. Discussion MCTs are extremely rare and associated with poor prognoses 2) in a field where data are very sparse. MCT studies were reported previously by researchers in Italy, 10) the Mayo Clinic 11) and the British Columbia Registry 12) as well as the Spanish Tertiary Surgical Center. 13) However, limited studies have been done in China. To our knowledge, larger studies of Chinese patients usually focused on benign tumors 14, 15) because MCTs account for only 6.0% of cardiac tumors in China. 16) Though there was literature about MCT treatment evaluation of Chinese patients, 17) more detailed and comprehensive studies should be performed on MCTs to potentially improve therapy.
We collected information on 14 patients diagnosed with MCTs in Fuwai Hospital. The mean age at tumor diagnosis was 47 years, confirming the conclusion that the peak incidence of MCTs appear in the fifth decade of life. Unlike some previous reports, 17, 18) the sex predilection showed more male patients were affected in our study. The right atrium was more susceptible to MCTs, consistent with the previous Chinese study. 19) MCT patients in our group were symptomatic at the time of diagnosis, with high frequencies of dyspnea (8, 57 .1%) and pericardial effusion (8, 57.1%). The latter symptom seems rare in a related study. Only a few articles reported a similar result. 10, 14) According to the guideline for pericardial diseases, 20) one of the most common non-infectious causes for pericardial effusion is pericardial tumor, e.g., primary cardiac lymphoma. 21) A Chinese study also reported that the proportion of pericardium involvement in the malignant tumors (25.8%) was significantly higher than in benign tumors. 14) However, five patients in our study showed pericardial effusion without pericardial involvement, possibly resulting from tumor stimulation. We suspected factors secreted by MCTs promoted malignant pericardial effusion, such as vascular endothelial growth factor and angiopoietin-2, which are released in malignant diseases as a result of rapid cell proliferation, and the associated relative ischemia and hypoxia, in local tumor tissues. 22, 23) It has been suggested that most patients presenting with malignant pericardial effusion have poor prognoses. 24) We also observed that patients with pericardial effusion seem have shorter mean survival time (7 months versus 11 months). Consistent with previous reports, MCTs more often invaded the right atrium, and sarcoma accounts for most primary heart malignancies. 1, 25) Multiple cardiovascular imaging techniques can be used to provide comprehensive morphological information on cardiac mass, among which echocardiography, usually as the first-line diagnostic test. 26, 27) After that, more information is needed to help differentiate between benign and GUO, ET AL Figure 3 . A: Inflammatory cell infiltration on myocardium of the pheochromocytoma patient (A1, A3) and the sarcoma patient (A2, A4). B: SDHB protein expression on myocardium of the health control (B1) and the pheochromocytoma patient (B2). Scale bars = 50 μm. malignant tumors; in this regard, CT and MRI have played increasingly important roles in evaluating cardiac neoplasms. CT is capable of detecting calcification and generally has more reliable image quality, while MR imaging has better soft-tissue contrast. 28) Six surgery patients had pathology diagnosis and imaging of CT or MR, four (66.7%) imaging reports were consistent with pathology results, while two cases were hard to define. The value of cardiovascular imaging is to identify potential complications arising from the tumor and inform management decisions. 29) In our group, six patients suffered coronary artery mobility from tumor influence, which was considered unusual in some reports; 30, 31) some studies based on Asian populations also lack information on the percentage of coronary artery involvement. 19, 32) They complained of increased chest pain after physical activity, a common manifestation among coronary artery patients. 33) Therefore, this indication seen in MCT patients suggest the coronary artery may be involved. We also reported histopathological subtypes of sarcoma and their frequencies, confirming angiosarcoma (3/7, 42.9%) is the most common histologic type. All angiosarcomas in our group arose from the right atrium, with two extending into the tricuspid valve. The tumor was large at the time of presentation, sometimes as large as 9 x 7 x 5 cm, consistent with a review of angio-THE CHARACTERISTICS OF PRIMARY CARDIAC TUMORS sarcomas, 34) Two patients' samples were positive for classic markers of angiosarcoma: 35) CD31 and CD34. WeibelPalade bodies were found in another patient's tissue by electron microscope.
Previous literature demonstrated that most pheochromocytomas resulted from mutations in SDHX genes and SDHX mutations would lead to decrease in SDHB protein; 36) thus, we stained SDHB in pheochromocytoma samples and found decreased SDHB levels.
We performed extensive survival analyses among different treatment on MCTs. Despite the overall poor prognosis of MCTs, survival has improved in surgery patients compared to those who received conservative treatment only. Survival increased significantly in two patients who underwent heart transplantation; both of them remain alive for 14 years after surgery with no complications. Patients who did not undergo surgery had a high risk of tumor metastasis and embolism accidents. Five patients were not candidates for surgical treatment (two patients had renal metastases); therefore, disease severity may also influence prognosis. Although the lower mortality of surgery group has been reported based on primary cardiac tumor, more work is needed to evaluate the effect on MCT patients. 32, 37) Additionally, heart transplants yielded better survival rates. The long survival time from heart transplantation was also revealed by a literature review. The mean survival time of patients was 12 months, even though 7 of them survived for a mean of 27 months without evidence of disease recurrence. 38) We suspected better prognoses of transplantation results from complete resection, which is crucial in increasing survival time. The median survival time for those who underwent a complete surgical excision was significantly longer than those without.
11) A similar result was reported, finding that negative surgical margin status was important for survival after malignant cardiac tumor resection. 17) Therefore, heart transplantation may provide a better outcome and a higher survival rate. However, uncertainty in obtaining a suitable donor heart makes autotransplantation an alternative choice for complex, left-sided tumors. 39) Study limitations: The sample size was relatively small compared to other MCT studies. Considering the morbidity associated with MCTs, it is challenging to recruit a large cohort from a single-center; therefore, more information from multicenter studies is needed to validate our findings.
Conclusion
A high frequency of pericardial effusion and coronary artery involvement appeared in our group. Our data suggests that heart transplant recipients had better outcomes among patients who underwent surgical treatment.
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